Dr. Parker on the Rationale for the RADICALS-RT Trial in Prostate Cancer

Chris Parker, MD, discusses the rationale for the phase III RADICALS-RT trial in prostate cancer.

Website:
Twitter:
Facebook:
LinkedIn:

cancer,oncology,